Dr Reddy's plans to enter into Japanese market

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2014

Singapore: Dr Reddy's Laboratories Limited is planning to make a fresh foray into the Japanese market. "We are explorin...Read more

Japan team creates liver from stem cells

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

Singapore: A team of scientists from Japan have created a functioning human liver from stem cells, raising hopes of manu...Read more

Eisai launches implantable anti-tumor agent

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jan, 2013

Singapore: Nobelpharma and Eisai launched Gliadel 7.7 mg Implant (carmustine), an antineoplastic agent, in Japan on Janu...Read more

Takeda submits plea for cetilistat approval in Japan

Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 31 Oct, 2012

Singapore: Takeda Pharmaceutical has submitted a new drug application (NDA) to the Ministry of Health, Labor and Welfare...Read more

Australia to grow Chinese anti-cancer fruit

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Dec, 2012

Singapore: University of Queensland (UQ) is soon going to globally launch a delicious berry-like ancient Chinese red bay...Read more

Siemens renews partnership with Japanese lab solutions firm

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 20 Jul, 2012

Singapore: Sysmex Corporation and Siemens Healthcare Diagnostics have announced the signing of a five-year global supply...Read more

Sucampo, Takeda file patent suit against Aunchen

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 11 Feb, 2013

Singapore: Sucampo (an affiliate of Sucampo Pharmaceuticals), R-Tech Ueno, Takeda Pharmaceutical, and certain affiliate...Read more

Chugai to invest $160 mn in Singapore

Japan |  Influencers | By BioSpectrum Bureau  | 0 Comment | 11 Oct, 2012

Japan's Chugai Pharmaceutical, which pursues cutting-edge biopharmaceutical, antibody, and molecular targeted research t...Read more

Eisai cancer drug gets orphan drug designation from Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2012

Singapore: Eisai has received orphan drug designation from Japan's Ministry of Labour, Health and Welfare for its multi...Read more

Japan files criminal complaint against Novartis

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jan, 2014

Singapore: Japan's health ministry has lodged a criminal complaint against the local wing of the leading Swiss drug make...Read more

Daiichi Sankyo enrolls patients for edoxaban trial

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Oct, 2012

Singapore: Japan-headquartered Daiichi Sankyo has completed patient enrollment in the global Hokusai-VTE phase III study...Read more

Daiichi Sankyo extends Medidata Clinical Cloud use to China

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2013

Singapore: Daiichi Sankyo is expanding its use of US-based Medidata Solutions' cloud-based platform to support clinical ...Read more

Daiichi, Amplimmune join hands for protein R&D

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jan, 2013

Singapore: Daiichi Sankyo and Amplimmune have entered into a strategic collaboration to develop a new therapeutic prote...Read more

Sankyo halts phase III trial of cancer drug

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

Singapore: The independent Data Monitoring Committee (DMC) of the phase III MARQUEE (Met inhibitor ARQ 197 plus Erlotin...Read more

Bioscience firms queue up for Japan market

Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

Japan, which has the lowest infant mortality rate and highest adult life expectancy in the world, is fast turning into a...Read more

Mylan and Pfizer enter deal for EpiPen in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2012

Singapore: Mylan Specialty, a subsidiary of Mylan, and Pfizer entered into a license agreement, under which Pfizer will ...Read more

Eisai, UCL form neuro R&D alliance

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 Dec, 2012

Singapore: University College London (UCL) and Japanese pharmaceutical company Eisai, have entered into a new agreement ...Read more

First-of-its-kind stroke symposium concludes in Tokyo

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 Sep, 2012

Singapore: Stroke, the destruction of brain tissue from blockage or rupture of blood vessels, is one of the leading caus...Read more